UC Research Investigates Drug-taking Pregnant Mothers
UC Research Investigates Needs of Drug-taking
Pregnant Mothers
May 3,
2013
Drug-dependent pregnant women are
very high-risk, with high rates of chronic physical and
mental health problems including depression and hepatitis C,
University of Canterbury (UC) research has
found.
Women on methadone maintenance are around
six times more likely to be welfare dependent and three
times more likely to have no formal educational
qualifications, lead research author and clinical
psychologist Dr Alison Davie-Gray says.
``Nearly
half of the methadone group we studied were facing pregnancy
with little or no partner support, compared to a group of
randomly-selected pregnant women who had 90 percent
support.
``During pregnancy, more than half of the
methadone group continued to use some licit and illicit
drugs and nearly all were cigarette smokers; whilst in the
other group, 17 percent of women reported smoking cigarettes
and 22 percent reported drinking alcohol.
``Our
study showed evidence of the effectiveness of methadone
maintenance in reducing maternal use of illicit opiates.
While, in both groups, the prevalence of significant
substance use among pregnant women was of concern there was,
nevertheless, an encouraging trend for substance use to
reduce over the course of pregnancy,’’ Dr Davie-Gray
says.
The study was carried out by UC’s
Canterbury Child Development Research Group, under the
leadership of Professor Lianne Woodward, in collaboration
with the Canterbury District Health Board.
The
research, published in the Neurotoxicology and
Teratology journal, investigated maternal
psycho-social risk and drug use in 81 pregnant women,
enrolled in methadone maintenance and 107 non-drug-taking
women.
``Recent research indicates that in New
Zealand, an estimated 10,000 adults are opiate-dependent.
For these individuals, opioid substitution treatment using
methadone maintenance is the treatment of choice and
pregnant women are prioritised for this service. In
Christchurch, typically 20 to 30 infants are born each year
to women on the Christchurch methadone
programme.
``Understanding the family environments
of infants born to mothers experiencing problems with drug
dependence is vital to improving services.
``As
families with significant daily challenges, their support
needs are likely to extend beyond the neonatal
period.
``Specialist ante-natal and neonatal teams
at Christchurch Women’s Hospital work together with the
Christchurch methadone programme to assist opiate-dependent
women during pregnancy and for a short time after the births
of their children.
``However, longer-term targeted
intervention for families is lacking. This UC study aims to
address a number of important issues concerning the needs of
these children and families with the broader goal of
improving prevention and intervention strategies aimed at
reducing risks associated with parental drug
dependence,’’ Dr Davie-Gray
says.
ENDS